Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
Introduction: We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses. We aimed to assess the effectiveness of MSC to impr...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579416300018 |